{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T09:00:10Z","timestamp":1767085210390},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,11,1]]},"DOI":"10.1093\/alcalc\/agh093","type":"journal-article","created":{"date-parts":[[2004,9,30]],"date-time":"2004-09-30T00:13:34Z","timestamp":1096503214000},"page":"542-547","source":"Crossref","is-referenced-by-count":46,"title":["COMBINED THERAPY: WHAT DOES ACAMPROSATE AND NALTREXONE COMBINATION TELL US?"],"prefix":"10.1093","volume":"39","author":[{"given":"FALK","family":"KIEFER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KLAUS","family":"WIEDEMANN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,9,29]]},"reference":[{"key":"key\n\t\t\t\t20171011020037_B1","unstructured":"Anton, R. F., Kranzler, H. R. and Meyer, R. E. (1995) Neurobehavioral aspects of the pharmacotherapy of alcohol dependence. Clinical Neuroscience3, 145\u2013154."},{"key":"key\n\t\t\t\t20171011020037_B2","doi-asserted-by":"crossref","unstructured":"Berglund, M., Thealander, S., Salaspuro, Franck, J., Andr\u00e9asson, S. and \u00d6jehagen, A. (2003) Treatment of Alcohol Abuse: An Evidence-Based Review. Alcoholism: Clinical and Experimental Research27, 1645\u20131656.","DOI":"10.1097\/01.ALC.0000090144.99832.19"},{"key":"key\n\t\t\t\t20171011020037_B3","doi-asserted-by":"crossref","unstructured":"COMBINE Study Group (2003) Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study. Alcoholism: Clinical and Experimental Research27, 1123\u20131131.","DOI":"10.1097\/01.ALC.0000078020.92938.0B"},{"key":"key\n\t\t\t\t20171011020037_B4","doi-asserted-by":"crossref","unstructured":"Heinz, A., Lober, S., Georgi, A., Wrase, J., Hermann, D., Rey, E. R., Wellek, S. and Mann, K. (2003) Reward craving and withdrawal relief craving: assessment of different motivational pathways to alcohol intake. Alcohol and Alcoholism38, 35\u201339.","DOI":"10.1093\/alcalc\/agg005"},{"key":"key\n\t\t\t\t20171011020037_B5","doi-asserted-by":"crossref","unstructured":"Heyser, C. J., Moc, K. and Koob, G. F. (2003) Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats. Neuropsychopharmacology28, 1463\u20131471.","DOI":"10.1038\/sj.npp.1300175"},{"key":"key\n\t\t\t\t20171011020037_B6","doi-asserted-by":"crossref","unstructured":"Heyser, C. J., Schulteis, G. and Koob, G. F. (1997) Increased ethanol self-administration after a period of imposed ethanol deprivation in rats trained in a limited access paradigm. Alcoholism: Clinical and Experimental Research21, 784\u2013791.","DOI":"10.1111\/j.1530-0277.1997.tb03840.x"},{"key":"key\n\t\t\t\t20171011020037_B7","doi-asserted-by":"crossref","unstructured":"Johnson, B. A., Roache, J. D., Javors, M. A., DiClemente, C. C., Cloninger, C. R., Prihoda, T. J., Bordnick, P. S., Ait-Daoud, N. and Hensler, J. (2000) Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial. JAMA284, 963\u2013971.","DOI":"10.1001\/jama.284.8.963"},{"key":"key\n\t\t\t\t20171011020037_B8","doi-asserted-by":"crossref","unstructured":"Johnson, B. A., O'Malley, S. S., Ciraulo, D. A., Roache, J. D., Chambers, R. A., Sarid-Segal, O. and Couper, D. (2003) Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects. Journal of Clinical Psychopharmacology23, 281\u2013293.","DOI":"10.1097\/01.jcp.0000084029.22282.bb"},{"key":"key\n\t\t\t\t20171011020037_B9","doi-asserted-by":"crossref","unstructured":"Kiefer, F., Jahn, H., Tarnaske, T. et al. (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Archives of General Psychiatry60, 92\u201399.","DOI":"10.1001\/archpsyc.60.1.92"},{"key":"key\n\t\t\t\t20171011020037_B10","doi-asserted-by":"crossref","unstructured":"Kiefer, F., Jahn, H., Holzbach, R., Briken, P., Stracke, R. and Wiedemann, K. (2003) Die NALCAM-Studie: Wirksamkeit, Vertr\u00e4glichkeit, Outcome. Sucht49, 342\u2013351.","DOI":"10.1024\/suc.2003.49.6.342"},{"key":"key\n\t\t\t\t20171011020037_B11","unstructured":"Kiefer, F., Jahn, H. and Wiedemann, K. (2004) Impact of gender for the pharmacological abstinence maintenance treatment of alcoholism. European Psychiatry19 (Suppl. 1), 47."},{"key":"key\n\t\t\t\t20171011020037_B12","doi-asserted-by":"crossref","unstructured":"Kiefer, F., Helwig, H., Tarnaske, T., Otte, C., Jahn, H. and Wiedemann, K. (2004) Pharmacological relapse prevention of alcoholism: predictors of outcome. European Addiction Research, in press.","DOI":"10.1159\/000083037"},{"key":"key\n\t\t\t\t20171011020037_B13","doi-asserted-by":"crossref","unstructured":"Kim, S. G., Han, B. D., Park, J. M., Kim, M. J. and Stromberg, M. F. (2004) Effect of the combination of naltrexone and acamprosate on alcohol intake in mice. Psychiatry and Clinical Neuroscience58, 30\u201336.","DOI":"10.1111\/j.1440-1819.2004.01189.x"},{"key":"key\n\t\t\t\t20171011020037_B14","doi-asserted-by":"crossref","unstructured":"Kranzler, H. R. and Van Kirk, J. (2001) Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcoholism: Clinical and Experimental Research25, 1335\u20131341.","DOI":"10.1111\/j.1530-0277.2001.tb02356.x"},{"key":"key\n\t\t\t\t20171011020037_B15","doi-asserted-by":"crossref","unstructured":"Lesch, O. M., Riegler, A., Gutierrez, K., Hertling, I., Ramskogler, K., Semler, B., Zoghlami, A., Benda, N. and Walter, H. (2001) The European acamprosate trials: conclusions for research and therapy. Journal of Biomedical Science8, 89\u201395.","DOI":"10.1007\/BF02255976"},{"key":"key\n\t\t\t\t20171011020037_B16","doi-asserted-by":"crossref","unstructured":"Mann, K., Lehert, P. and Morgan, M. Y. (2004) The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcoholism: Clinical and Experimental Research28, 51\u201363.","DOI":"10.1097\/01.ALC.0000108656.81563.05"},{"key":"key\n\t\t\t\t20171011020037_B17","unstructured":"Mason, B. J. (2001) Treatment of alcohol dependent outpatients with acamprosate: a clinical review. Journal of Clinical Psychiatry62 (Suppl. 20), 42\u201348."},{"key":"key\n\t\t\t\t20171011020037_B18","doi-asserted-by":"crossref","unstructured":"Mason, B. J., Goodman, A. M., Dixon, R. M., Hameed, M. H., Hulot, T., Wesnes, K., Hunter, J. A. and Boyeson, M. G. (2002) A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone. Neuropsychopharmacology27, 596\u2013606.","DOI":"10.1016\/S0893-133X(02)00368-8"},{"key":"key\n\t\t\t\t20171011020037_B19","doi-asserted-by":"crossref","unstructured":"Spanagel, R. and Holter, S. M. (1999) Long-term alcohol self-administration with repeated alcohol deprivation phases: an animal model of alcoholism? Alcohol and Alcoholism34, 231\u2013243.","DOI":"10.1093\/alcalc\/34.2.231"},{"key":"key\n\t\t\t\t20171011020037_B20","doi-asserted-by":"crossref","unstructured":"Streeton, C. and Whelan, G. (2001) Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials. Alcohol and Alcoholism36, 544\u2013552.","DOI":"10.1093\/alcalc\/36.6.544"},{"key":"key\n\t\t\t\t20171011020037_B21","doi-asserted-by":"crossref","unstructured":"Stromberg, M. F., Mackler, S. A., Volpicelli, J. R. and O'Brien, C. P. (2001) Effect of acamprosate and naltrexone, alone or in combination on ethanol consumption. Alcohol23, 109\u2013116.","DOI":"10.1016\/S0741-8329(00)00137-3"},{"key":"key\n\t\t\t\t20171011020037_B22","doi-asserted-by":"crossref","unstructured":"Verheul, R., van den Brink, W. and Geerlings, P. (1999) A three-pathway psychobiological model of craving for alcohol. Alcohol and Alcoholism34, 197\u2013222.","DOI":"10.1093\/alcalc\/34.2.197"},{"key":"key\n\t\t\t\t20171011020037_B23","unstructured":"Volpicelli, J. R., Clay, K. L., Watson, N. T. and O'Brien, C. P. (1995) Naltrexone in the treatment of alcoholism: predicting response to naltrexone. Journal of Clinical Psychiatry56 (Suppl. 7), 39\u201344."},{"key":"key\n\t\t\t\t20171011020037_B24","doi-asserted-by":"crossref","unstructured":"Whitworth, A. B., Fischer, F., Lesch, O. M., Nimmerrichter, A., Oberbauer, H., Platz, T., Potgieter, A., Walter, H. and Fleischhacker, W. W. (1996) Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet347, 1438\u20131442.","DOI":"10.1016\/S0140-6736(96)91682-7"}],"container-title":["Alcohol and Alcoholism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/alcalc\/article-pdf\/39\/6\/542\/557339\/agh093.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T07:19:31Z","timestamp":1585898371000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/alcalc\/article\/39\/6\/542\/211327\/COMBINED-THERAPY-WHAT-DOES-ACAMPROSATE-AND"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,29]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2004,9,29]]},"published-print":{"date-parts":[[2004,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/alcalc\/agh093","relation":{},"ISSN":["1464-3502","0735-0414"],"issn-type":[{"value":"1464-3502","type":"electronic"},{"value":"0735-0414","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,11]]},"published":{"date-parts":[[2004,9,29]]}}}